Informations générales (source: ClinicalTrials.gov)
Visual Exploration and Attention : Studies in Patients With Schizophrenia and Autism Spectrum Disorders
Observational
University Hospital, Strasbourg, France (Voir sur ClinicalTrials)
juin 2009
décembre 2016
29 juin 2024
The aim of the protocol is to better understand the impairments in visual processing, as
such impairments may induce social interaction difficulties in subjects with autism
spectrum disorders (adults and children) and schizophrenia, like face exploration.The
same protocol will be used for the three populations, each population being compared with
matched controls. The explorations are designed to test two different hypotheses
regarding the mechanisms of the visual perception difficulties of the two populations.
Even though difficulties to extract the global form of objects have been described in
both subjects with autism and schizophrenia, we will test two different hypotheses for
the two populations. We will test the hypothesis that subjects with autism display an
advantage for the processing of local information arising at an early level of
processing, whereas disorders observed in patients with schizophrenia originate from
attention disorders. The protocol includes three consecutive studies, each one being
applied in each of the three populations.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre de Ressources Autisme Pôle adultes (68) - Espace Autisme 68 - 68000 - Colmar - France | MURAD Ayman, MD | Contact (sur clinicalTrials) | |||
| Clinique Lautréamont - 59120 - Loos - France | GONIN Olivier, MD | Contact (sur clinicalTrials) | |||
| INSERM U666 ; Pôle de Psychiatrie - Service de Psychiatrie Adulte- HUS - 67091 - Strasbourg - France | GIERSCH Anne, MD | Contact (sur clinicalTrials) | |||
| Pôle départemental du Centre de Ressources Autisme pour adultes (67) - Etablissement public de santé Alsace-Nord (site de Brumath) - 67170 - Brumath - France | HOCHNER Arielle, MD | Contact (sur clinicalTrials) | |||
| Pôle régional du Centre de Ressources Autisme pour enfants et adolescents - Unité d'évaluation des troubles du développement Hôpital de l'Elsau - Pôle de Psychiatrie - Unité d'évaluation des troubles du développement Hôpital de l'Elsau - HUS - 67000 - Strasbourg - France | GRAS-VINCENDON Agnès, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- IQ above 70, as evaluated with the WAIS III in adults and with the WISC in children
- signed consent
- DSM IV criteria in case of autism spectrum disorders or schizophrenia
- IQ above 70, as evaluated with the WAIS III in adults and with the WISC in children
- signed consent
- DSM IV criteria in case of autism spectrum disorders or schizophrenia
- grave or non stabilized somatic pathology
- pathology affecting the central nervous system; other than the studied pathologies
- intake of psychotropic drug, except for patients
- invalidating sensory processes